Birdwatch Note
2025-03-16 22:22:58 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
GLP-1 is produced naturally in humans by intestinal L-Cells 30-60 minutes after eating. GLP-1 receptor antagonists simulate the effect of GLP-1 hormones The claim of them being "reptile venom" is misleading, as they were developed in labs to treat diabetes. en.wikipedia.org/wiki/Glucagon-like_peptide-1#Secretion en.wikipedia.org/wiki/GLP-1_receptor_antagonist en.wikipedia.org/wiki/Semaglutide en.wikipedia.org/wiki/Incretin en.wikipedia.org/wiki/Incretin_mimetic
Written by 18669D120364DBAC09F0DE9AE2A2BBABD1A559E3946856BA255C85ABCCD73CCE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1901342889805812021
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1901398813601935466
- noteId - 1901398813601935466
- participantId -
- noteAuthorParticipantId - 18669D120364DBAC09F0DE9AE2A2BBABD1A559E3946856BA255C85ABCCD73CCE Participant Details
- createdAtMillis - 1742163778101
- tweetId - 1901342889805812021
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- GLP-1 is produced naturally in humans by intestinal L-Cells 30-60 minutes after eating. GLP-1 receptor antagonists simulate the effect of GLP-1 hormones The claim of them being "reptile venom" is misleading, as they were developed in labs to treat diabetes. en.wikipedia.org/wiki/Glucagon-like_peptide-1#Secretion en.wikipedia.org/wiki/GLP-1_receptor_antagonist en.wikipedia.org/wiki/Semaglutide en.wikipedia.org/wiki/Incretin en.wikipedia.org/wiki/Incretin_mimetic
Note Ratings
| rated at | rated by | |
| 2025-03-16 21:12:04 -0500 | Rating Details | |
| 2025-03-16 19:48:41 -0500 | Rating Details | |
| 2025-03-16 19:47:37 -0500 | Rating Details | |
| 2025-03-16 19:20:04 -0500 | Rating Details | |
| 2025-03-16 19:06:18 -0500 | Rating Details | |
| 2025-03-16 18:43:04 -0500 | Rating Details | |
| 2025-03-16 18:39:09 -0500 | Rating Details | |
| 2025-03-16 17:42:19 -0500 | Rating Details | |
| 2025-03-18 21:43:55 -0500 | Rating Details | |
| 2025-03-17 17:06:02 -0500 | Rating Details | |
| 2025-03-17 16:53:26 -0500 | Rating Details | |
| 2025-03-17 14:34:19 -0500 | Rating Details | |
| 2025-03-17 10:48:09 -0500 | Rating Details | |
| 2025-03-17 10:23:57 -0500 | Rating Details | |
| 2025-03-17 10:00:42 -0500 | Rating Details | |
| 2025-03-17 09:45:30 -0500 | Rating Details | |
| 2025-03-17 08:41:41 -0500 | Rating Details | |
| 2025-03-17 04:32:11 -0500 | Rating Details | |
| 2025-03-17 03:33:08 -0500 | Rating Details | |
| 2025-03-17 02:15:57 -0500 | Rating Details | |
| 2025-03-16 23:57:11 -0500 | Rating Details | |
| 2025-03-16 23:48:28 -0500 | Rating Details | |
| 2025-03-16 21:45:12 -0500 | Rating Details | |
| 2025-03-16 19:30:10 -0500 | Rating Details | |
| 2025-03-24 02:53:08 -0500 | Rating Details | |
| 2025-03-18 04:06:43 -0500 | Rating Details | |
| 2025-03-18 02:57:43 -0500 | Rating Details | |
| 2025-03-17 13:57:05 -0500 | Rating Details | |
| 2025-03-17 11:01:27 -0500 | Rating Details | |
| 2025-03-17 09:13:40 -0500 | Rating Details | |
| 2025-03-16 23:59:16 -0500 | Rating Details | |
| 2025-03-16 20:30:18 -0500 | Rating Details | |
| 2025-03-16 19:40:35 -0500 | Rating Details | |
| 2025-03-16 19:16:33 -0500 | Rating Details | |
| 2025-03-16 18:36:20 -0500 | Rating Details | |
| 2025-03-16 17:53:34 -0500 | Rating Details | |
| 2025-03-16 17:43:55 -0500 | Rating Details | |
| 2025-03-17 15:55:02 -0500 | Rating Details | |
| 2025-03-17 12:15:42 -0500 | Rating Details | |
| 2025-03-17 11:17:30 -0500 | Rating Details | |
| 2025-03-17 10:01:10 -0500 | Rating Details | |
| 2025-03-17 03:30:03 -0500 | Rating Details | |
| 2025-03-16 23:44:49 -0500 | Rating Details | |
| 2025-03-16 23:42:04 -0500 | Rating Details | |
| 2025-03-16 21:40:18 -0500 | Rating Details | |
| 2025-03-16 20:02:51 -0500 | Rating Details | |
| 2025-03-16 20:01:12 -0500 | Rating Details | |
| 2025-03-16 19:43:22 -0500 | Rating Details | |
| 2025-03-16 18:41:52 -0500 | Rating Details | |
| 2025-03-16 18:09:04 -0500 | Rating Details | |
| 2025-03-16 17:44:08 -0500 | Rating Details | |
| 2025-03-20 05:47:39 -0500 | Rating Details | |
| 2025-03-17 11:56:14 -0500 | Rating Details | |
| 2025-03-17 10:56:39 -0500 | Rating Details | |
| 2025-03-17 09:34:22 -0500 | Rating Details | |
| 2025-03-17 08:36:26 -0500 | Rating Details | |
| 2025-03-17 06:09:45 -0500 | Rating Details | |
| 2025-03-17 02:20:29 -0500 | Rating Details | |
| 2025-03-16 23:32:32 -0500 | Rating Details | |
| 2025-03-16 21:58:46 -0500 | Rating Details | |
| 2025-03-16 20:11:55 -0500 | Rating Details | |
| 2025-03-16 19:42:10 -0500 | Rating Details | |
| 2025-03-17 12:21:51 -0500 | Rating Details | |
| 2025-03-17 09:37:17 -0500 | Rating Details | |
| 2025-03-17 08:43:36 -0500 | Rating Details | |
| 2025-03-17 02:03:58 -0500 | Rating Details | |
| 2025-03-17 01:02:12 -0500 | Rating Details | |
| 2025-03-16 23:23:15 -0500 | Rating Details | |
| 2025-03-16 20:53:12 -0500 | Rating Details | |
| 2025-03-16 19:42:18 -0500 | Rating Details | |
| 2025-03-16 18:59:09 -0500 | Rating Details | |
| 2025-03-16 17:39:30 -0500 | Rating Details | |
| 2025-03-17 19:20:41 -0500 | Rating Details | |
| 2025-03-17 12:49:38 -0500 | Rating Details | |
| 2025-03-17 09:14:21 -0500 | Rating Details | |
| 2025-03-17 08:43:46 -0500 | Rating Details | |
| 2025-03-16 23:49:45 -0500 | Rating Details | |
| 2025-03-16 22:09:13 -0500 | Rating Details | |
| 2025-03-16 21:34:10 -0500 | Rating Details | |
| 2025-03-16 20:58:53 -0500 | Rating Details | |
| 2025-03-16 20:57:27 -0500 | Rating Details | |
| 2025-03-16 19:24:57 -0500 | Rating Details | |
| 2025-03-17 13:45:27 -0500 | Rating Details | |
| 2025-03-17 06:02:19 -0500 | Rating Details | |
| 2025-03-16 22:40:53 -0500 | Rating Details | |
| 2025-03-16 21:51:56 -0500 | Rating Details | |
| 2025-03-16 18:03:46 -0500 | Rating Details | |
| 2025-03-16 18:03:32 -0500 | Rating Details | |
| 2025-03-16 17:54:01 -0500 | Rating Details | |
| 2025-03-16 17:46:17 -0500 | Rating Details | |
| 2025-03-16 17:32:35 -0500 | Rating Details | |
| 2025-03-18 01:15:10 -0500 | Rating Details | |
| 2025-03-17 20:00:38 -0500 | Rating Details | |
| 2025-03-17 10:53:15 -0500 | Rating Details | |
| 2025-03-17 10:11:56 -0500 | Rating Details | |
| 2025-03-17 05:28:03 -0500 | Rating Details | |
| 2025-03-16 20:39:28 -0500 | Rating Details | |
| 2025-03-16 20:23:24 -0500 | Rating Details | |
| 2025-03-16 17:53:41 -0500 | Rating Details | |
| 2025-03-16 17:45:37 -0500 | Rating Details | |
| 2025-03-16 17:34:10 -0500 | Rating Details | |
| 2025-03-17 21:34:51 -0500 | Rating Details | |
| 2025-03-17 13:03:39 -0500 | Rating Details | |
| 2025-03-17 12:15:40 -0500 | Rating Details | |
| 2025-03-17 08:33:54 -0500 | Rating Details | |
| 2025-03-17 07:18:33 -0500 | Rating Details | |
| 2025-03-17 00:48:27 -0500 | Rating Details | |
| 2025-03-16 23:50:03 -0500 | Rating Details | |
| 2025-03-16 22:51:10 -0500 | Rating Details | |
| 2025-03-16 21:25:27 -0500 | Rating Details | |
| 2025-03-16 21:02:55 -0500 | Rating Details | |
| 2025-03-16 20:45:51 -0500 | Rating Details | |
| 2025-03-16 20:13:12 -0500 | Rating Details | |
| 2025-03-16 19:29:40 -0500 | Rating Details | |
| 2025-03-16 18:56:42 -0500 | Rating Details | |
| 2025-03-16 18:25:36 -0500 | Rating Details | |
| 2025-03-16 18:21:03 -0500 | Rating Details | |
| 2025-03-16 18:08:34 -0500 | Rating Details | |
| 2025-03-16 18:07:24 -0500 | Rating Details | |
| 2025-03-16 17:58:58 -0500 | Rating Details | |
| 2025-03-16 17:56:32 -0500 | Rating Details | |
| 2025-03-16 17:41:45 -0500 | Rating Details | |
| 2025-03-17 18:52:49 -0500 | Rating Details | |
| 2025-03-17 14:47:08 -0500 | Rating Details | |
| 2025-03-17 12:17:03 -0500 | Rating Details | |
| 2025-03-17 11:37:48 -0500 | Rating Details | |
| 2025-03-17 11:37:26 -0500 | Rating Details | |
| 2025-03-17 11:26:21 -0500 | Rating Details | |
| 2025-03-17 11:11:00 -0500 | Rating Details | |
| 2025-03-17 08:40:36 -0500 | Rating Details | |
| 2025-03-17 07:28:53 -0500 | Rating Details | |
| 2025-03-17 01:57:53 -0500 | Rating Details | |
| 2025-03-17 01:15:17 -0500 | Rating Details | |
| 2025-03-17 01:08:33 -0500 | Rating Details | |
| 2025-03-17 00:19:16 -0500 | Rating Details | |
| 2025-03-16 23:41:56 -0500 | Rating Details | |
| 2025-03-16 22:38:21 -0500 | Rating Details | |
| 2025-03-16 20:52:05 -0500 | Rating Details | |
| 2025-03-16 20:30:16 -0500 | Rating Details | |
| 2025-03-16 19:44:28 -0500 | Rating Details | |
| 2025-03-16 19:33:12 -0500 | Rating Details | |
| 2025-03-16 19:05:25 -0500 | Rating Details | |
| 2025-03-16 19:03:27 -0500 | Rating Details | |
| 2025-03-16 18:51:35 -0500 | Rating Details | |
| 2025-03-16 17:49:36 -0500 | Rating Details | |
| 2025-03-16 17:48:54 -0500 | Rating Details | |
| 2025-03-17 09:43:05 -0500 | Rating Details | |
| 2025-03-17 05:31:31 -0500 | Rating Details | |
| 2025-03-16 20:39:21 -0500 | Rating Details | |
| 2025-03-16 19:22:52 -0500 | Rating Details | |
| 2025-03-16 18:58:42 -0500 | Rating Details | |
| 2025-03-16 18:02:20 -0500 | Rating Details | |
| 2025-03-16 17:46:22 -0500 | Rating Details | |
| 2025-03-17 06:22:14 -0500 | Rating Details | |
| 2025-03-17 05:24:43 -0500 | Rating Details | |
| 2025-03-16 19:43:07 -0500 | Rating Details | |
| 2025-03-16 19:11:54 -0500 | Rating Details | |
| 2025-03-16 18:02:36 -0500 | Rating Details | |
| 2025-03-16 17:48:00 -0500 | Rating Details | |
| 2025-03-17 22:11:22 -0500 | Rating Details | |
| 2025-03-16 23:02:05 -0500 | Rating Details | |
| 2025-03-16 19:57:26 -0500 | Rating Details | |
| 2025-03-17 13:15:22 -0500 | Rating Details | |
| 2025-03-17 11:57:53 -0500 | Rating Details | |
| 2025-03-17 07:53:56 -0500 | Rating Details | |
| 2025-03-16 20:59:29 -0500 | Rating Details | |
| 2025-03-16 17:51:25 -0500 | Rating Details | |
| 2025-03-16 23:08:47 -0500 | Rating Details | |
| 2025-03-16 20:34:16 -0500 | Rating Details | |
| 2025-03-16 20:10:28 -0500 | Rating Details | |
| 2025-03-16 18:31:04 -0500 | Rating Details | |
| 2025-03-16 18:29:47 -0500 | Rating Details | |
| 2025-03-17 10:06:31 -0500 | Rating Details | |
| 2025-03-17 07:58:12 -0500 | Rating Details | |
| 2025-03-16 21:05:50 -0500 | Rating Details | |
| 2025-03-16 20:52:08 -0500 | Rating Details | |
| 2025-03-16 18:45:11 -0500 | Rating Details | |
| 2025-03-17 01:22:09 -0500 | Rating Details | |
| 2025-03-16 20:52:51 -0500 | Rating Details | |
| 2025-03-16 19:14:10 -0500 | Rating Details | |
| 2025-03-16 17:32:24 -0500 | Rating Details | |
| 2025-03-17 07:48:20 -0500 | Rating Details | |
| 2025-03-16 17:55:30 -0500 | Rating Details | |
| 2025-03-16 17:34:21 -0500 | Rating Details | |
| 2025-03-17 10:27:32 -0500 | Rating Details | |
| 2025-03-16 20:56:30 -0500 | Rating Details |